Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

NCT: NCT06660225 · RECRUITING

NCT IDNCT06660225
StatusRECRUITING
Start Date2026-06
Completion2031-01

Brief Summary

The goal of this clinical trial is to learn if deep brain stimulation (DBS) works to treat refractory obsessive-compulsive disorder (OCD). The main questions it aims to answer are: * Assess the effects of the anteromedial sub-thalamic nucleus (amSTN)stimulation on obsessive/compulsive symptoms. * Map the amSTN using neuronal responses \[single unit and local field potentials (LFP) recordings\] at rest and under high frequency stimulation during surgery. * Record chronic brain activity with the implanted pulse generator and look for neuronal signatures correlated with symptom severity. Researchers will compare active deep brain stimulation to a placebo (sham stimulation) to see if DBS works to treat refractory OCD. Participants will: * Undergo surgery for the implantation of a deep brain stimulation device * Follow-up visits every three weeks with study staff * 6 month follow-up for the next 2-3 years after first year of study participation is complete

Frequently Asked Questions

What is Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder?

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder is a clinical trial registered under NCT06660225. Current status: RECRUITING.

What is the status of NCT06660225?

The current status of NCT06660225 (Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder) is: RECRUITING.

When did Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder start?

Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.